Living Mirrors with Dr. James Cooke Amanda Feilding on psychedelic research | Living Mirrors #53
Jun 2, 2021
Amanda Feilding, a trailblazing drug policy reformer and founder of the Beckley Foundation, dives deep into the transformative world of psychedelics. She shares fascinating insights from her early experiences with LSD, highlighting its role in understanding consciousness. The conversation explores the stigma surrounding psychedelics and their therapeutic potential, discussing groundbreaking research like psilocybin trials for depression. Amanda emphasizes the urgent need for intelligent drug policy reform and increased accessibility to psychedelic therapies in the face of a mental health crisis.
AI Snips
Chapters
Transcript
Episode notes
Early Interest in Mysticism
- Amanda Feilding developed an early interest in mysticism, influenced by her isolated upbringing and family's diverse spiritual beliefs.
- She left school at 16 to travel to Sri Lanka and further explore these interests.
First LSD Experience
- Feilding's first LSD experience in 1965 resonated with her childhood mystical experiences.
- A later traumatic experience involving LSD led her to retreat and reflect.
Meeting Bart Huges
- Feilding met Bart Huges, a scientist with a theory about consciousness and psychedelics.
- This encounter sparked her lifelong mission to explore and understand consciousness.